BBV Review

Advertisement
%PM, %16 %956 %2019

Viral Hepatitis in Europe, an overview

People with chronic Hepatitis B virus (HBV) and/or Hepatitis C virus (HCV) are at risk of serious liver disease such as liver cirrhosis and hepatocellular carcinoma (HCC) and remain infectious to others. Because chronic HBV and HCV infections are typically asymptomatic, notification data reflect national screening and testing practices and do not give accurate insights into the prevalence of infections. Thus, to adequately inform primary or secondary prevention efforts, supplementary information such as prevalence data are needed. People with chronic Hepatitis B virus (HBV) and/or Hepatitis C virus (HCV) are at risk of serious liver disease such as liver cirrhosis and hepatocellular carcinoma (HCC) and remain infectious to others. Because chronic HBV and HCV infections are typically asymptomatic, notification data reflect national screening and testing practices and do not give accurate insights into the prevalence of infections. Thus, to adequately inform primary or secondary prevention efforts, supplementary information such as prevalence data are needed.   Author: Dr Siamak Tonekaboni

Latest from Dr Siamak Tonekaboni

Twitter Updates

BBV Review @DrLoomba @JVLazarus There are more advanced ML & AI methods including LIVERFASt a product of Fibronostics which ha… https://t.co/hTlk8Bilc2
Monday, 15 February 2021 10:54
BBV Review RT @HenryEChang: HCV treatment in 2020: How to translate highly effective therapies into elimination strategies→https://t.co/gvgyBRaitj vi…
Friday, 04 September 2020 11:46
BBV Review RT @HenryEChang: Sustainable Development Goals for HBV elimination in South Africa: challenges, progress & the road ahead→https://t.co/TCu…
Wednesday, 22 May 2019 09:04
BBV Review RT @grahamscooke: Two helpful pieces on HCV reinfection from @GregDore2 @ProfJohnDillon at a time when we're trying to get access to retrea…
Sunday, 05 May 2019 13:34

Events & Conferences

For accurate and independent information on blood borne viruses, subscribe to our free newsletter.